Vicki L Sato is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 1.32 Million shares of VIR, which is worth approximately $10.7 Million. The most recent transaction as insider was on May 30, 2024, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.32M
0% 3M change
0.61% 12M change
Total Value Held $10.7 Million

VICKI L SATO Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2024
BUY
Grant, award, or other acquisition
-
8,000 Added 0.6%
1,323,351 Common Stock
Jun 30 2023
SELL
Open market or private sale
$443,880 $24.66 p/Share
18,000 Reduced 1.35%
1,315,351 Common Stock
May 22 2023
BUY
Grant, award, or other acquisition
-
6,027 Added 0.45%
1,333,351 Common Stock
Mar 08 2023
SELL
Open market or private sale
$405,151 $22.59 p/Share
17,935 Reduced 1.33%
1,327,324 Common Stock
Feb 08 2023
SELL
Open market or private sale
$513,802 $28.68 p/Share
17,915 Reduced 1.31%
1,345,259 Common Stock
Jan 09 2023
SELL
Open market or private sale
$462,744 $25.83 p/Share
17,915 Reduced 1.3%
1,363,174 Common Stock
Dec 08 2022
SELL
Open market or private sale
$462,386 $25.81 p/Share
17,915 Reduced 1.28%
1,381,089 Common Stock
Nov 08 2022
SELL
Open market or private sale
$490,512 $27.38 p/Share
17,915 Reduced 1.26%
1,399,004 Common Stock
Oct 10 2022
SELL
Open market or private sale
$370,303 $20.67 p/Share
17,915 Reduced 1.25%
1,416,919 Common Stock
Sep 08 2022
SELL
Open market or private sale
$392,338 $21.9 p/Share
17,915 Reduced 1.23%
1,434,834 Common Stock
Aug 08 2022
SELL
Open market or private sale
$542,645 $30.29 p/Share
17,915 Reduced 1.22%
1,452,749 Common Stock
Jul 08 2022
SELL
Open market or private sale
$523,476 $29.22 p/Share
17,915 Reduced 1.2%
1,470,664 Common Stock
Jun 08 2022
SELL
Open market or private sale
$468,836 $26.17 p/Share
17,915 Reduced 1.19%
1,488,579 Common Stock
May 24 2022
SELL
Open market or private sale
$80,369 $23.82 p/Share
3,374 Reduced 0.22%
1,506,494 Common Stock
May 23 2022
BUY
Grant, award, or other acquisition
-
6,405 Added 0.42%
1,509,868 Common Stock
May 09 2022
SELL
Open market or private sale
$299,835 $20.62 p/Share
14,541 Reduced 0.96%
1,503,463 Common Stock
Apr 28 2022
SELL
Open market or private sale
$378,365 $21.12 p/Share
17,915 Reduced 1.17%
1,518,004 Common Stock
Jan 18 2022
SELL
Open market or private sale
$567,318 $37.39 p/Share
15,173 Reduced 0.98%
1,535,919 Common Stock
Dec 20 2021
SELL
Open market or private sale
$836,087 $55.1 p/Share
15,174 Reduced 0.97%
1,551,092 Common Stock
Nov 26 2021
SELL
Open market or private sale
$558,403 $36.8 p/Share
15,174 Reduced 0.96%
1,566,266 Common Stock
Oct 19 2021
SELL
Open market or private sale
$599,525 $39.51 p/Share
15,174 Reduced 0.95%
1,581,440 Common Stock
Sep 17 2021
SELL
Open market or private sale
$799,518 $52.69 p/Share
15,174 Reduced 0.94%
1,596,614 Common Stock
Aug 19 2021
SELL
Open market or private sale
$681,920 $44.94 p/Share
15,174 Reduced 0.93%
1,611,788 Common Stock
Jul 19 2021
SELL
Open market or private sale
$565,838 $37.29 p/Share
15,174 Reduced 0.92%
1,626,962 Common Stock
Jun 21 2021
SELL
Open market or private sale
$703,770 $46.38 p/Share
15,174 Reduced 0.92%
1,642,136 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
DNLI
Denali Therapeutics Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
VLS

Vicki L Sato

Director
New York, NY

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR